SK279236B6 - Bezsérové bunkové kultúry na výrobu antigénov a sp - Google Patents
Bezsérové bunkové kultúry na výrobu antigénov a sp Download PDFInfo
- Publication number
- SK279236B6 SK279236B6 SK6590-90A SK659090A SK279236B6 SK 279236 B6 SK279236 B6 SK 279236B6 SK 659090 A SK659090 A SK 659090A SK 279236 B6 SK279236 B6 SK 279236B6
- Authority
- SK
- Slovakia
- Prior art keywords
- virus
- cells
- antigen
- matrix
- virus antigen
- Prior art date
Links
- 239000000427 antigen Substances 0.000 title claims abstract description 69
- 102000036639 antigens Human genes 0.000 title claims abstract description 69
- 108091007433 antigens Proteins 0.000 title claims abstract description 69
- 241000700605 Viruses Species 0.000 title claims abstract description 62
- 238000000034 method Methods 0.000 title claims abstract description 16
- 241000710831 Flavivirus Species 0.000 title claims abstract description 15
- 241000712891 Arenavirus Species 0.000 title claims abstract description 14
- 238000004113 cell culture Methods 0.000 title claims abstract description 13
- 238000002360 preparation method Methods 0.000 title claims abstract description 4
- 210000004027 cell Anatomy 0.000 claims abstract description 62
- 239000011159 matrix material Substances 0.000 claims abstract description 18
- 210000003501 vero cell Anatomy 0.000 claims abstract description 9
- 238000000746 purification Methods 0.000 claims abstract description 5
- 230000001419 dependent effect Effects 0.000 claims abstract description 4
- 230000002779 inactivation Effects 0.000 claims abstract description 4
- 210000004102 animal cell Anatomy 0.000 claims abstract description 3
- 210000005260 human cell Anatomy 0.000 claims abstract description 3
- 238000004519 manufacturing process Methods 0.000 claims description 26
- 239000002609 medium Substances 0.000 claims description 14
- 230000010412 perfusion Effects 0.000 claims description 14
- 238000000855 fermentation Methods 0.000 claims description 10
- 230000004151 fermentation Effects 0.000 claims description 10
- 230000003612 virological effect Effects 0.000 claims description 9
- 239000012679 serum free medium Substances 0.000 claims description 5
- 229920002307 Dextran Polymers 0.000 claims description 3
- 230000001464 adherent effect Effects 0.000 claims description 3
- 239000011521 glass Substances 0.000 claims description 3
- 108010010803 Gelatin Proteins 0.000 claims description 2
- 239000008273 gelatin Substances 0.000 claims description 2
- 229920000159 gelatin Polymers 0.000 claims description 2
- 235000019322 gelatine Nutrition 0.000 claims description 2
- 235000011852 gelatine desserts Nutrition 0.000 claims description 2
- 239000004033 plastic Substances 0.000 claims description 2
- 229920003023 plastic Polymers 0.000 claims description 2
- 230000035899 viability Effects 0.000 claims description 2
- 239000000203 mixture Substances 0.000 abstract description 5
- 230000010261 cell growth Effects 0.000 abstract 1
- 230000002101 lytic effect Effects 0.000 abstract 1
- 210000002966 serum Anatomy 0.000 abstract 1
- 239000000758 substrate Substances 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 description 13
- 241000710771 Tick-borne encephalitis virus Species 0.000 description 11
- 239000001963 growth medium Substances 0.000 description 7
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 6
- 229960005486 vaccine Drugs 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 241000287828 Gallus gallus Species 0.000 description 4
- 235000013330 chicken meat Nutrition 0.000 description 4
- 238000012258 culturing Methods 0.000 description 4
- 239000002054 inoculum Substances 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 3
- 210000002308 embryonic cell Anatomy 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 206010014599 encephalitis Diseases 0.000 description 2
- 238000011031 large-scale manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000000644 propagated effect Effects 0.000 description 2
- 210000000130 stem cell Anatomy 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 230000009385 viral infection Effects 0.000 description 2
- 241000282552 Chlorocebus aethiops Species 0.000 description 1
- 241000867610 Chlorocebus pygerythrus Species 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 206010014596 Encephalitis Japanese B Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 241000710924 Togaviridae Species 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 210000000270 basal cell Anatomy 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 201000011475 meningoencephalitis Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 210000005084 renal tissue Anatomy 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000000405 serological effect Effects 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2531/00—Microcarriers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24151—Methods of production or purification of viral material
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Compounds Of Unknown Constitution (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT2928/89A AT393356B (de) | 1989-12-22 | 1989-12-22 | Verfahren zur herstellung von fsme-virus-antigen |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SK659090A3 SK659090A3 (en) | 1998-08-05 |
| SK279236B6 true SK279236B6 (sk) | 1998-08-05 |
Family
ID=3542524
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK6590-90A SK279236B6 (sk) | 1989-12-22 | 1990-12-21 | Bezsérové bunkové kultúry na výrobu antigénov a sp |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0506714B1 (cs) |
| JP (1) | JP2633391B2 (cs) |
| AT (2) | AT393356B (cs) |
| CA (1) | CA2071954C (cs) |
| CZ (1) | CZ281804B6 (cs) |
| DE (1) | DE59007659D1 (cs) |
| DK (1) | DK0506714T3 (cs) |
| ES (1) | ES2067916T3 (cs) |
| FI (1) | FI98377C (cs) |
| HR (1) | HRP921354A2 (cs) |
| HU (1) | HU213886B (cs) |
| NO (1) | NO310305B1 (cs) |
| RU (1) | RU2082757C1 (cs) |
| SK (1) | SK279236B6 (cs) |
| WO (1) | WO1991009935A1 (cs) |
| YU (1) | YU242390A (cs) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996015231A2 (en) * | 1994-11-10 | 1996-05-23 | Immuno Aktiengesellschaft | Method for producing biologicals in protein-free culture |
| CA2228128C (fr) * | 1995-08-01 | 2011-03-29 | Pasteur Merieux Serums & Vaccins | Procede de production industrielle d'un vaccin contre l'encephalite japonaise et vaccin obtenu |
| FR2737412B1 (fr) * | 1995-08-01 | 1997-10-24 | Pasteur Merieux Serums Vacc | Procede de production d'un vaccin contre le virus de l'encephalite japonaise et vaccin obtenu par ce procede |
| EP1057889B1 (en) * | 1998-10-05 | 2009-04-22 | The Research Foundation for Microbial Diseases of Osaka University | Enhanced immunogen for inactivated vaccine for infection with japanese encephalitis viruses and process for producing the same |
| AT409379B (de) | 1999-06-02 | 2002-07-25 | Baxter Ag | Medium zur protein- und serumfreien kultivierung von zellen |
| US6855535B2 (en) * | 2001-12-10 | 2005-02-15 | Baxter Healthcare S.A. | Method of large scale production of Hepatitis A virus |
| US6951752B2 (en) | 2001-12-10 | 2005-10-04 | Bexter Healthcare S.A. | Method for large scale production of virus antigen |
| JP2007068401A (ja) * | 2003-08-07 | 2007-03-22 | Chemo Sero Therapeut Res Inst | 西ナイルウイルスワクチン |
| EP3255152A1 (en) * | 2007-12-27 | 2017-12-13 | Baxalta GmbH | Cell culture processes |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT358167B (de) * | 1978-12-22 | 1980-08-25 | Immuno Ag | Verfahren zur herstellung von fruehsommer- -meningoenzephalitis-virus (fsme-virus)- -vakzinen |
| SE445116B (sv) * | 1979-09-12 | 1986-06-02 | Pharmacia Fine Chemicals Ab | Sett att odla celler pa mikroberare med fibronektinytskikt |
| NO161446C (no) * | 1981-03-13 | 1989-08-16 | Damon Biotech Inc | Fremgangsmaate for dyrking av celler som er avhengige av forankring. |
| SE8103138L (sv) * | 1981-05-19 | 1982-11-20 | Pharmacia Fine Chemicals Ab | Mikroberare for odling av forankringsberoende celler |
| CA1206900A (en) * | 1981-12-21 | 1986-07-02 | Raymond L. Downs | Hollow glass shell microcarrier for growth of cell cultures, and method of shell manufacture |
| AT385203B (de) * | 1985-04-26 | 1988-03-10 | Immuno Ag | Verfahren zur herstellung einer fruehsommermeningoenzephalitis-virus (fsme-virus)-vakzine |
| DD274336A3 (de) * | 1985-10-03 | 1989-12-20 | Npo Biolar | Verfahren zur Gewinnung einer Mikroträgersubstanz für die Zellkultivierung |
-
1989
- 1989-12-22 AT AT2928/89A patent/AT393356B/de not_active IP Right Cessation
-
1990
- 1990-12-21 ES ES91900666T patent/ES2067916T3/es not_active Expired - Lifetime
- 1990-12-21 EP EP19910900666 patent/EP0506714B1/de not_active Expired - Lifetime
- 1990-12-21 SK SK6590-90A patent/SK279236B6/sk not_active IP Right Cessation
- 1990-12-21 CZ CS906590A patent/CZ281804B6/cs not_active IP Right Cessation
- 1990-12-21 HU HU9202009A patent/HU213886B/hu unknown
- 1990-12-21 WO PCT/AT1990/000128 patent/WO1991009935A1/de not_active Ceased
- 1990-12-21 JP JP50113291A patent/JP2633391B2/ja not_active Expired - Fee Related
- 1990-12-21 CA CA 2071954 patent/CA2071954C/en not_active Expired - Lifetime
- 1990-12-21 DK DK91900666T patent/DK0506714T3/da not_active Application Discontinuation
- 1990-12-21 AT AT91900666T patent/ATE113652T1/de not_active IP Right Cessation
- 1990-12-21 RU SU905052769A patent/RU2082757C1/ru not_active IP Right Cessation
- 1990-12-21 YU YU242390A patent/YU242390A/sh unknown
- 1990-12-21 DE DE59007659T patent/DE59007659D1/de not_active Expired - Fee Related
-
1992
- 1992-06-18 FI FI922851A patent/FI98377C/fi active
- 1992-06-19 NO NO19922422A patent/NO310305B1/no not_active IP Right Cessation
- 1992-11-25 HR HRP921354 patent/HRP921354A2/xx not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| HUT65410A (en) | 1994-06-28 |
| WO1991009935A1 (de) | 1991-07-11 |
| AT393356B (de) | 1991-10-10 |
| HU9202009D0 (en) | 1992-10-28 |
| ATE113652T1 (de) | 1994-11-15 |
| FI98377B (fi) | 1997-02-28 |
| FI922851A0 (fi) | 1992-06-18 |
| JP2633391B2 (ja) | 1997-07-23 |
| FI922851A7 (fi) | 1992-06-18 |
| DK0506714T3 (da) | 1995-04-18 |
| NO922422D0 (no) | 1992-06-19 |
| SK659090A3 (en) | 1998-08-05 |
| CA2071954C (en) | 1996-06-18 |
| EP0506714B1 (de) | 1994-11-02 |
| RU2082757C1 (ru) | 1997-06-27 |
| FI98377C (fi) | 1997-06-10 |
| YU242390A (sh) | 1993-05-28 |
| CZ281804B6 (cs) | 1997-02-12 |
| HU213886B (en) | 1997-11-28 |
| DE59007659D1 (de) | 1994-12-08 |
| CA2071954A1 (en) | 1991-06-23 |
| JPH05502581A (ja) | 1993-05-13 |
| EP0506714A1 (de) | 1992-10-07 |
| HRP921354A2 (en) | 1996-02-29 |
| CZ659090A3 (en) | 1996-11-13 |
| NO922422L (no) | 1992-08-17 |
| NO310305B1 (no) | 2001-06-18 |
| ES2067916T3 (es) | 1995-04-01 |
| ATA292889A (de) | 1991-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2008207588B2 (en) | Methods for producing an active constituent of a pharmaceutical or a diagnostic agent in an MDCK cell suspension culture | |
| Van Hemert et al. | Homogeneous cultivation of animal cells for the production of virus and virus products | |
| US4024020A (en) | Method of cell culture on polyacrylonitrile surface | |
| JPH0748277A (ja) | Ａ型肝炎ウィルスワクチン | |
| SK279236B6 (sk) | Bezsérové bunkové kultúry na výrobu antigénov a sp | |
| US7666654B2 (en) | Method for preparing viral material | |
| CN1970080A (zh) | 用悬浮的Vero细胞生产病毒疫苗的方法 | |
| US5719051A (en) | Perfusion system and a method for the large scale production of virus or virus antigen | |
| US3935066A (en) | Cell lines | |
| US4169761A (en) | Process for the cultivation of viruses | |
| US9932562B2 (en) | Drain down and re-feed of microcarrier bioreactor | |
| Hirtenstein et al. | Microcarrier-bound mammalian cells | |
| NO860180L (cs) | ||
| Nicholson | Growth of fish cell lines on microcarriers | |
| US3616203A (en) | Virus culture and method | |
| RU2142816C1 (ru) | Способ получения антигерпетической вакцины и лекарственная форма на ее основе | |
| RU2014084C1 (ru) | Способ получения вирионной герпетической вакцины | |
| RU2816765C1 (ru) | Способ получения культуральной инактивированной вакцины против вируса бешенства | |
| CN114306587B (zh) | 一种低血清乙型脑炎灭活疫苗的制备方法及乙型脑炎灭活疫苗 | |
| BACHRACH | THE purpose of this report is to review pro | |
| JP2003219866A (ja) | イヌ腎由来浮遊性培養細胞株およびこれを用いたワクチンまたは感染診断用病原微生物の生産方法 | |
| NO751303L (cs) | ||
| HK1062029A1 (zh) | 細胞培育人細菌的增值 | |
| HK1062029B (en) | Multiplication of viruses in a cell culture |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Patent lapsed due to non-payment of maintenance fees |
Effective date: 20091221 |